Genprex Inc (GNPX)
3.14
+0.72
(+29.75%)
USD |
NASDAQ |
May 31, 16:00
3.54
+0.40
(+12.74%)
After-Hours: 20:00
Genprex Free Cash Flow: -23.17M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -23.17M |
| December 31, 2023 | -24.81M |
| September 30, 2023 | -24.40M |
| June 30, 2023 | -24.18M |
| March 31, 2023 | -20.56M |
| December 31, 2022 | -17.68M |
| September 30, 2022 | -16.37M |
| June 30, 2022 | -14.43M |
| March 31, 2022 | -12.87M |
| December 31, 2021 | -14.37M |
| September 30, 2021 | -17.23M |
| June 30, 2021 | -16.61M |
| March 31, 2021 | -17.19M |
| December 31, 2020 | -16.27M |
| September 30, 2020 | -11.97M |
| Date | Value |
|---|---|
| June 30, 2020 | -11.94M |
| March 31, 2020 | -10.86M |
| December 31, 2019 | -7.866M |
| September 30, 2019 | -8.178M |
| June 30, 2019 | -7.707M |
| March 31, 2019 | -8.391M |
| December 31, 2018 | -6.950M |
| September 30, 2018 | -5.037M |
| June 30, 2018 | -4.219M |
| March 31, 2018 | -1.777M |
| December 31, 2017 | -2.235M |
| September 30, 2017 | -2.889M |
| June 30, 2017 | -2.447M |
| March 31, 2017 | -1.850M |
| December 31, 2016 | -1.338M |
Free Cash Flow Range, Past 5 Years
-24.81M
Minimum
Dec 2023
-7.707M
Maximum
Jun 2019
-15.93M
Average
-16.32M
Median
Free Cash Flow Benchmarks
| Lifecore Biomedical Inc | -- |
| Jaguar Health Inc | -30.34M |
| Aquestive Therapeutics Inc | -26.60M |
| TFF Pharmaceuticals Inc | -14.82M |
| Calidi Biotherapeutics Inc | -22.68M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.298M |
| Cash from Investing (Quarterly) | -0.0158M |
| Cash from Financing (Quarterly) | 6.793M |
| Free Cash Flow Per Share (Quarterly) | -3.284 |
| Free Cash Flow Yield | -504.6% |